Autologous stem cell transplantation in NK/T-cell lymphoma: Prognostic impact of EBV-DNA in a multinational cohort-A study by the EBMT Lymphoma Working Party.

Among patients with advanced‐stage disease at diagnosis, those receiving upfront auto‐HCT had numerically higher 3‐year OS (64.1% [95% CI: 49.1–75.8]) compared to those transplanted after ≥2 lines (40.6% [95% CI: 21.6–58.8]; P = 0.210), although this did not reach statistical significance (Table S4 , Figure S1B ).

also in 111,027 other papers